By Eli Hughes —
Researchers at the University of Louisville are working on a possible treatment for COVID-19 that uses a protein grown in tobacco.
This treatment is being designed as a preventative nasal spray that researchers are hoping will reach human clinical trials by the end of the year.
Kenneth Palmer, director of U of L’s Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, said that the protein active in the treatment was first studied by his team for its usefulness in preventing HIV.
“We knew that this protein had very good activity against HIV and we wondered some years ago whether it would have activity against other viruses,” Palmer said.